Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Candel Therapeutics (CADL) Times Interest Earned (2022 - 2025)

Candel Therapeutics' Times Interest Earned history spans 2 years, with the latest figure at -$15.33 for Q4 2023.

  • On a quarterly basis, Times Interest Earned fell 9.39% to -$15.33 in Q4 2023 year-over-year; TTM through Dec 2023 was -$14.79, a 34.72% increase, with the full-year FY2025 number at -$22.78, down 42.66% from a year prior.
  • Times Interest Earned hit -$15.33 in Q4 2023 for Candel Therapeutics, down from -$13.25 in the prior quarter.
  • Over the last five years, Times Interest Earned for CADL hit a ceiling of -$13.25 in Q3 2023 and a floor of -$20.12 in Q2 2022.